 | • レポートコード：MRC2-11QY12307 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、91ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料はイブルチニブのグローバル市場について調査・分析したレポートです。種類別（5mg、10mg、140mg）市場規模、用途別（マントル細胞リンパ腫、慢性リンパ性白血病、ワルデンストレームマクログロブリン血症、再発/難治性辺縁帯リンパ腫、慢性移植片対宿主病）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別イブルチニブの競争状況、市場シェア ・世界のイブルチニブ市場：種類別市場規模 2015年-2020年（5mg、10mg、140mg） ・世界のイブルチニブ市場：種類別市場規模予測 2021年-2026年（5mg、10mg、140mg） ・世界のイブルチニブ市場：用途別市場規模 2015年-2020年（マントル細胞リンパ腫、慢性リンパ性白血病、ワルデンストレームマクログロブリン血症、再発/難治性辺縁帯リンパ腫、慢性移植片対宿主病） ・世界のイブルチニブ市場：用途別市場規模予測 2021年-2026年（マントル細胞リンパ腫、慢性リンパ性白血病、ワルデンストレームマクログロブリン血症、再発/難治性辺縁帯リンパ腫、慢性移植片対宿主病） ・北米のイブルチニブ市場分析：米国、カナダ ・ヨーロッパのイブルチニブ市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのイブルチニブ市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のイブルチニブ市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのイブルチニブ市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：AbbVie (Pharmacyclics)、Johnson & Johnson (Janssen Biotech)、SP Laboratories ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Imbruvica is a small molecule drug that binds permanently to a protein, Bruton’s tyrosine kinase (BTK), that is important in B cells; the drug is used to treat B cell cancers like mantle cell lymphoma, chronic lymphocytic leukemia, and Waldenström’s macroglobulinemia.
Market Analysis and Insights: Global Imbruvica Market
The global Imbruvica market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Imbruvica Scope and Market Size
Imbruvica market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Imbruvica market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
AbbVie (Pharmacyclics)
Johnson & Johnson (Janssen Biotech)
SP Laboratories
…
Market segment by Type, the product can be split into
5 mg
10 mg
140 mg
Market segment by Application, split into
Mantle Cell Lymphoma
Chronic Lymphocytic Leukemia
Waldenström’s Macroglobulinemia
Relapsed/Refractory Marginal Zone Lymphoma
Chronic Graft-Versus-Host-Disease
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Imbruvica Revenue
1.4 Market by Type
1.4.1 Global Imbruvica Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 5 mg
1.4.3 10 mg
1.4.4 140 mg
1.5 Market by Application
1.5.1 Global Imbruvica Market Share by Application: 2020 VS 2026
1.5.2 Mantle Cell Lymphoma
1.5.3 Chronic Lymphocytic Leukemia
1.5.4 Waldenström’s Macroglobulinemia
1.5.5 Relapsed/Refractory Marginal Zone Lymphoma
1.5.6 Chronic Graft-Versus-Host-Disease
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Imbruvica Market Perspective (2015-2026)
2.2 Global Imbruvica Growth Trends by Regions
2.2.1 Imbruvica Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Imbruvica Historic Market Share by Regions (2015-2020)
2.2.3 Imbruvica Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Imbruvica Market Growth Strategy
2.3.6 Primary Interviews with Key Imbruvica Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Imbruvica Players by Market Size
3.1.1 Global Top Imbruvica Players by Revenue (2015-2020)
3.1.2 Global Imbruvica Revenue Market Share by Players (2015-2020)
3.1.3 Global Imbruvica Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Imbruvica Market Concentration Ratio
3.2.1 Global Imbruvica Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Imbruvica Revenue in 2019
3.3 Imbruvica Key Players Head office and Area Served
3.4 Key Players Imbruvica Product Solution and Service
3.5 Date of Enter into Imbruvica Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Imbruvica Historic Market Size by Type (2015-2020)
4.2 Global Imbruvica Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Imbruvica Market Size by Application (2015-2020)
5.2 Global Imbruvica Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Imbruvica Market Size (2015-2020)
6.2 Imbruvica Key Players in North America (2019-2020)
6.3 North America Imbruvica Market Size by Type (2015-2020)
6.4 North America Imbruvica Market Size by Application (2015-2020)
7 Europe
7.1 Europe Imbruvica Market Size (2015-2020)
7.2 Imbruvica Key Players in Europe (2019-2020)
7.3 Europe Imbruvica Market Size by Type (2015-2020)
7.4 Europe Imbruvica Market Size by Application (2015-2020)
8 China
8.1 China Imbruvica Market Size (2015-2020)
8.2 Imbruvica Key Players in China (2019-2020)
8.3 China Imbruvica Market Size by Type (2015-2020)
8.4 China Imbruvica Market Size by Application (2015-2020)
9 Japan
9.1 Japan Imbruvica Market Size (2015-2020)
9.2 Imbruvica Key Players in Japan (2019-2020)
9.3 Japan Imbruvica Market Size by Type (2015-2020)
9.4 Japan Imbruvica Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Imbruvica Market Size (2015-2020)
10.2 Imbruvica Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Imbruvica Market Size by Type (2015-2020)
10.4 Southeast Asia Imbruvica Market Size by Application (2015-2020)
11 India
11.1 India Imbruvica Market Size (2015-2020)
11.2 Imbruvica Key Players in India (2019-2020)
11.3 India Imbruvica Market Size by Type (2015-2020)
11.4 India Imbruvica Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Imbruvica Market Size (2015-2020)
12.2 Imbruvica Key Players in Central & South America (2019-2020)
12.3 Central & South America Imbruvica Market Size by Type (2015-2020)
12.4 Central & South America Imbruvica Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 AbbVie (Pharmacyclics)
13.1.1 AbbVie (Pharmacyclics) Company Details
13.1.2 AbbVie (Pharmacyclics) Business Overview
13.1.3 AbbVie (Pharmacyclics) Imbruvica Introduction
13.1.4 AbbVie (Pharmacyclics) Revenue in Imbruvica Business (2015-2020))
13.1.5 AbbVie (Pharmacyclics) Recent Development
13.2 Johnson & Johnson (Janssen Biotech)
13.2.1 Johnson & Johnson (Janssen Biotech) Company Details
13.2.2 Johnson & Johnson (Janssen Biotech) Business Overview
13.2.3 Johnson & Johnson (Janssen Biotech) Imbruvica Introduction
13.2.4 Johnson & Johnson (Janssen Biotech) Revenue in Imbruvica Business (2015-2020)
13.2.5 Johnson & Johnson (Janssen Biotech) Recent Development
13.3 SP Laboratories
13.3.1 SP Laboratories Company Details
13.3.2 SP Laboratories Business Overview
13.3.3 SP Laboratories Imbruvica Introduction
13.3.4 SP Laboratories Revenue in Imbruvica Business (2015-2020)
13.3.5 SP Laboratories Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Imbruvica Key Market Segments
Table 2. Key Players Covered: Ranking by Imbruvica Revenue
Table 3. Ranking of Global Top Imbruvica Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Imbruvica Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of 5 mg
Table 6. Key Players of 10 mg
Table 7. Key Players of 140 mg
Table 8. Global Imbruvica Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 9. Global Imbruvica Market Size by Regions (US$ Million): 2020 VS 2026
Table 10. Global Imbruvica Market Size by Regions (2015-2020) (US$ Million)
Table 11. Global Imbruvica Market Share by Regions (2015-2020)
Table 12. Global Imbruvica Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 13. Global Imbruvica Market Share by Regions (2021-2026)
Table 14. Market Top Trends
Table 15. Key Drivers: Impact Analysis
Table 16. Key Challenges
Table 17. Imbruvica Market Growth Strategy
Table 18. Main Points Interviewed from Key Imbruvica Players
Table 19. Global Imbruvica Revenue by Players (2015-2020) (Million US$)
Table 20. Global Imbruvica Market Share by Players (2015-2020)
Table 21. Global Top Imbruvica Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Imbruvica as of 2019)
Table 22. Global Imbruvica by Players Market Concentration Ratio (CR5 and HHI)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Imbruvica Product Solution and Service
Table 25. Date of Enter into Imbruvica Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Imbruvica Market Size by Type (2015-2020) (Million US$)
Table 28. Global Imbruvica Market Size Share by Type (2015-2020)
Table 29. Global Imbruvica Revenue Market Share by Type (2021-2026)
Table 30. Global Imbruvica Market Size Share by Application (2015-2020)
Table 31. Global Imbruvica Market Size by Application (2015-2020) (Million US$)
Table 32. Global Imbruvica Market Size Share by Application (2021-2026)
Table 33. North America Key Players Imbruvica Revenue (2019-2020) (Million US$)
Table 34. North America Key Players Imbruvica Market Share (2019-2020)
Table 35. North America Imbruvica Market Size by Type (2015-2020) (Million US$)
Table 36. North America Imbruvica Market Share by Type (2015-2020)
Table 37. North America Imbruvica Market Size by Application (2015-2020) (Million US$)
Table 38. North America Imbruvica Market Share by Application (2015-2020)
Table 39. Europe Key Players Imbruvica Revenue (2019-2020) (Million US$)
Table 40. Europe Key Players Imbruvica Market Share (2019-2020)
Table 41. Europe Imbruvica Market Size by Type (2015-2020) (Million US$)
Table 42. Europe Imbruvica Market Share by Type (2015-2020)
Table 43. Europe Imbruvica Market Size by Application (2015-2020) (Million US$)
Table 44. Europe Imbruvica Market Share by Application (2015-2020)
Table 45. China Key Players Imbruvica Revenue (2019-2020) (Million US$)
Table 46. China Key Players Imbruvica Market Share (2019-2020)
Table 47. China Imbruvica Market Size by Type (2015-2020) (Million US$)
Table 48. China Imbruvica Market Share by Type (2015-2020)
Table 49. China Imbruvica Market Size by Application (2015-2020) (Million US$)
Table 50. China Imbruvica Market Share by Application (2015-2020)
Table 51. Japan Key Players Imbruvica Revenue (2019-2020) (Million US$)
Table 52. Japan Key Players Imbruvica Market Share (2019-2020)
Table 53. Japan Imbruvica Market Size by Type (2015-2020) (Million US$)
Table 54. Japan Imbruvica Market Share by Type (2015-2020)
Table 55. Japan Imbruvica Market Size by Application (2015-2020) (Million US$)
Table 56. Japan Imbruvica Market Share by Application (2015-2020)
Table 57. Southeast Asia Key Players Imbruvica Revenue (2019-2020) (Million US$)
Table 58. Southeast Asia Key Players Imbruvica Market Share (2019-2020)
Table 59. Southeast Asia Imbruvica Market Size by Type (2015-2020) (Million US$)
Table 60. Southeast Asia Imbruvica Market Share by Type (2015-2020)
Table 61. Southeast Asia Imbruvica Market Size by Application (2015-2020) (Million US$)
Table 62. Southeast Asia Imbruvica Market Share by Application (2015-2020)
Table 63. India Key Players Imbruvica Revenue (2019-2020) (Million US$)
Table 64. India Key Players Imbruvica Market Share (2019-2020)
Table 65. India Imbruvica Market Size by Type (2015-2020) (Million US$)
Table 66. India Imbruvica Market Share by Type (2015-2020)
Table 67. India Imbruvica Market Size by Application (2015-2020) (Million US$)
Table 68. India Imbruvica Market Share by Application (2015-2020)
Table 69. Central & South America Key Players Imbruvica Revenue (2019-2020) (Million US$)
Table 70. Central & South America Key Players Imbruvica Market Share (2019-2020)
Table 71. Central & South America Imbruvica Market Size by Type (2015-2020) (Million US$)
Table 72. Central & South America Imbruvica Market Share by Type (2015-2020)
Table 73. Central & South America Imbruvica Market Size by Application (2015-2020) (Million US$)
Table 74. Central & South America Imbruvica Market Share by Application (2015-2020)
Table 75. AbbVie (Pharmacyclics) Company Details
Table 76. AbbVie (Pharmacyclics) Business Overview
Table 77. AbbVie (Pharmacyclics) Product
Table 78. AbbVie (Pharmacyclics) Revenue in Imbruvica Business (2015-2020) (Million US$)
Table 79. AbbVie (Pharmacyclics) Recent Development
Table 80. Johnson & Johnson (Janssen Biotech) Company Details
Table 81. Johnson & Johnson (Janssen Biotech) Business Overview
Table 82. Johnson & Johnson (Janssen Biotech) Product
Table 83. Johnson & Johnson (Janssen Biotech) Revenue in Imbruvica Business (2015-2020) (Million US$)
Table 84. Johnson & Johnson (Janssen Biotech) Recent Development
Table 85. SP Laboratories Company Details
Table 86. SP Laboratories Business Overview
Table 87. SP Laboratories Product
Table 88. SP Laboratories Revenue in Imbruvica Business (2015-2020) (Million US$)
Table 89. SP Laboratories Recent Development
Table 90. Research Programs/Design for This Report
Table 91. Key Data Information from Secondary Sources
Table 92. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Imbruvica Market Share by Type: 2020 VS 2026
Figure 2. 5 mg Features
Figure 3. 10 mg Features
Figure 4. 140 mg Features
Figure 5. Global Imbruvica Market Share by Application: 2020 VS 2026
Figure 6. Mantle Cell Lymphoma Case Studies
Figure 7. Chronic Lymphocytic Leukemia Case Studies
Figure 8. Waldenström's Macroglobulinemia Case Studies
Figure 9. Relapsed/Refractory Marginal Zone Lymphoma Case Studies
Figure 10. Chronic Graft-Versus-Host-Disease Case Studies
Figure 11. Imbruvica Report Years Considered
Figure 12. Global Imbruvica Market Size YoY Growth 2015-2026 (US$ Million)
Figure 13. Global Imbruvica Market Share by Regions: 2020 VS 2026
Figure 14. Global Imbruvica Market Share by Regions (2021-2026)
Figure 15. Porter's Five Forces Analysis
Figure 16. Global Imbruvica Market Share by Players in 2019
Figure 17. Global Top Imbruvica Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Imbruvica as of 2019
Figure 18. The Top 10 and 5 Players Market Share by Imbruvica Revenue in 2019
Figure 19. North America Imbruvica Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Europe Imbruvica Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. China Imbruvica Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Japan Imbruvica Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Southeast Asia Imbruvica Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. India Imbruvica Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Central & South America Imbruvica Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Bottom-up and Top-down Approaches for This Report
Figure 27. Data Triangulation
Figure 28. Key Executives Interviewed
慢性リンパ性白血病（CLL）治療薬の世界市場（～2026年） Market Analysis and Insights: Global Chronic Lymphocytic Leukemia Therapeutics Market The global Chronic Lymphocytic Leukemia Therapeutics market size is projected to reach US$ 9390.9 million by 2026, from US$ 8411.2 million in 2020, at a CAGR of 10.8%% during 2021-2026. Global Chronic Lymphocytic L…- B細胞慢性リンパ球性白血病治療の世界市場（～2026年） Market Analysis and Insights: Global B-Cell Chronic Lymphocytic Leukemia Treatment Market The global B-Cell Chronic Lymphocytic Leukemia Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global B-Cell Chronic Lymphocy…
- 慢性リンパ性白血病（CLL）治療の世界市場（～2026年） Accumulation of functionally incompetent monocytes is referred as Chronic Lymphocytic Leukemia (CLL). Chronic Lymphocytic Leukemia is a type of monoclonal disorder and is commonly found in adults in western countries. Based on the severity, patients diagnosed with chronic lymphocytic leukemia die wi…
- 成人T細胞白血病/リンパ腫治療の世界市場（～2026年） Adult T-cell lymphoma/leukemia (ATL) is a rare T-cell lymphoproliferative neoplasm caused by human T-lymphotrophic virus 1. In its more common, aggressive forms, ATL carries one of the poorest prognoses of the non-Hodgkin lymphomas. The disease has clinical subtypes (ie, acute, lymphoma, chronic, an…
- 慢性骨髄性白血病治療の世界市場（～2026年） Chronic myeloid leukemia (CML) is also known as chronic myelogenous leukemia. It's a type of cancer that starts in certain blood-forming cells of the bone marrow. Market Analysis and Insights: Global Chronic Myelogenous Leukemia Treatment Market The global Chronic Myelogenous Leukemia Treatment mark…